Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.17)
# 2,690
Out of 4,711 analysts
283
Total ratings
58.78%
Success rate
-1.41%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Underweight | $183 → $195 | $224.15 | -13.00% | 6 | Dec 17, 2024 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $7.87 | +33.42% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.44 | +35.14% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $303.62 | +16.92% | 2 | Dec 17, 2024 | |
| HIMS Hims & Hers Health | Initiates: Overweight | $42 | $26.20 | +60.31% | 1 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $125.00 | -22.40% | 14 | Nov 5, 2024 | |
| ARDT Ardent Health Partners | Initiates: Overweight | $27 | $16.01 | +68.64% | 1 | Aug 12, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $4.18 | +19.62% | 12 | Aug 6, 2024 | |
| SWKS Skyworks Solutions | Maintains: Equal-Weight | $96 → $114 | $88.75 | +28.45% | 24 | Feb 7, 2023 | |
| ST Sensata Technologies Holding | Maintains: Overweight | $62 → $57 | $27.24 | +109.25% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $55.51 | +45.92% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $57.83 | -39.48% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.09 | +27.75% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $70.85 | +161.12% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $143.67 | +16.24% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $70.58 | -40.49% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $153.10 | +3.85% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $44.36 | +181.79% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $220.79 | -67.25% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $186.87 | +4.35% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $500.13 | -2.43% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $294.73 | +0.43% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $228.61 | +60.97% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $247.10 | +107.61% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $276.92 | -0.69% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $59.58 | +47.70% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $65.50 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $74.62 | +147.92% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $210.24 | +1.31% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $149.83 | -61.29% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $211.78 | -44.75% | 15 | Jun 16, 2020 |
Veeva Systems
Dec 17, 2024
Maintains: Underweight
Price Target: $183 → $195
Current: $224.15
Upside: -13.00%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $7.87
Upside: +33.42%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.44
Upside: +35.14%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $303.62
Upside: +16.92%
Hims & Hers Health
Dec 17, 2024
Initiates: Overweight
Price Target: $42
Current: $26.20
Upside: +60.31%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $125.00
Upside: -22.40%
Ardent Health Partners
Aug 12, 2024
Initiates: Overweight
Price Target: $27
Current: $16.01
Upside: +68.64%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $4.18
Upside: +19.62%
Skyworks Solutions
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $88.75
Upside: +28.45%
Sensata Technologies Holding
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $27.24
Upside: +109.25%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $55.51
Upside: +45.92%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $57.83
Upside: -39.48%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.09
Upside: +27.75%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $70.85
Upside: +161.12%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $143.67
Upside: +16.24%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $70.58
Upside: -40.49%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $153.10
Upside: +3.85%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $44.36
Upside: +181.79%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $220.79
Upside: -67.25%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $186.87
Upside: +4.35%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $500.13
Upside: -2.43%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $294.73
Upside: +0.43%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $228.61
Upside: +60.97%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $247.10
Upside: +107.61%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $276.92
Upside: -0.69%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $59.58
Upside: +47.70%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $65.50
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $74.62
Upside: +147.92%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $210.24
Upside: +1.31%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $149.83
Upside: -61.29%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $211.78
Upside: -44.75%